COVID-19 booster shots recommended by FDA advisory panel

Covid Vaccine Booster

By WVUA 23 News Reporter Aajene Robinson

Moderna and Johnson and Johnson are another step closer to getting COVID-19 booster shots into the arms of those who most need them in the U.S.

On Friday, a Federal Drug Administration advisory panel recommended the use of Moderna and J&J COVID-19 booster shots for patients who are older or who have health-compromising conditions.

UABHospital Alabama Vaccine Research Clinic Director Dr. Paul Goepfert said the recommendations are coming at a good time for those who took the vaccine early in the year.

Goepfert said the advisory panel unanimously decided that people who received the J&J vaccine should consider a booster as soon as they’re available to increase their protection.

“If it’s been six months, seven months since you’ve gotten your J&J vaccine it’s actually fine to just go ahead and boost now,” Goepfert said.

Because there’s limited availability of the Johnson and Johnson vaccine, Goepfert said patients may consider getting a Moderna or Pfizer vaccine as a booster instead.

“I think for the general population, I wouldn’t just go out and recommend it, I think they need to go out and talk to their doctor,” Goepfert said. “The safest thing to do would be to get another J&J shot, but if push comes to shove I think people are going to get the Pfizer or Moderna booster.”

Approval for Moderna and Johnson and Johnson booster shots will be decided in the coming weeks by the FDA and U.S. Centers for Disease Control and Prevention. The Pfizer vaccine is already available as a booster for those who initially took the two-dose Pfizer COVID-19 vaccine.

Categories: Archives, COVID-19, Local News